Recent Updates
Recently added Catalysts
ABBV Positive Sentiment

AbbVie Declares Quarterly Dividend The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.48 per share. The cash dividend is payable November ...

Friday, September 8, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: AbbVie Inc. has declared a quarterly cash dividend of $1.48 per share, payable on November 15, 2023, to shareholders on record by October 13, 2023. Since its founding in 2013, AbbVie has increased its dividend significantly by 270%. The company is recognized as a member of the S&P Dividend Aristocrats Index, underscoring its ongoing commitment to dividend increases over the years.
Price reaction · baseline $148.91 (2023-09-07 close) · hit after-hours · 2 other ABBV headline(s) in the window, move may be shared
day 0 close · peak
+0.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • AbbVie declared a quarterly cash dividend of $1.48 per share.
  • The company has increased its dividend by 270% since its inception in 2013.
  • AbbVie is part of the S&P Dividend Aristocrats Index, highlighting its consistent dividend growth.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+33%
120-day peak, hindsight
Typical move
1.4%
average across 15 past catalysts
Lead asset
paricalcitol
Phase 3 · Secondary Hyperparathyroidism

Full Press Release Details

NORTH CHICAGO, Ill. , Sept. 8, 2023 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV ) today declared a quarterly cash dividend of $1.48 per share.
The cash dividend is payable November 15, 2023 , to stockholders of record at the close of business on October 13, 2023 .
Since the company's inception in 2013, AbbVie has increased its dividend by 270 percent. AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on Twitter , Facebook , Instagram , YouTube and LinkedIn .

Frequently Asked Questions

What is AbbVie's quarterly cash dividend amount?

AbbVie has declared a quarterly cash dividend of $1.48 per share.

When is the dividend payable to shareholders?

The dividend will be payable on November 15, 2023.

What is the record date for AbbVie's dividend?

The record date for the dividend is October 13, 2023.

By how much has AbbVie increased its dividend since 2013?

AbbVie has increased its dividend by 270 percent since 2013.

What index is AbbVie a member of?

AbbVie is a member of the S&P Dividend Aristocrats Index.

ShareAdd on Google
Tags: ABBV Viatris Investor Conferences Healthcare AbbVie dividend S&P Dividend Aristocrats quarterly cash payment NYSE: ABBV
Last updated: Sep 8, 2023

Biotech snapshot

Cash runway
$6569M liquidity · $0M/mo burn
Low dilution risk
Lead asset
paricalcitolPhase 3
Secondary Hyperparathyroidism →

Catalyst track record

+33%
best trade around ABBV's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for ABBV.

See every catalyst's timing & PoA →